Kapikacchu (Mucuna pruriens): A Promising Indigenous Herbal Drug and Its Effect on Different Disease Conditions

Authors

  • Binod Bihari Dora Research Officer (Ayurveda) CCRAS, Regional Ayurveda Research Institute, Itanagar, Arunachal Pradesh, India.
  • Shobhit Kumar Research Officer (Ayurveda) CCRAS, Regional Ayurveda Research Institute, Itanagar, Arunachal Pradesh, India.

DOI:

https://doi.org/10.37591/rrjot.v7i3.75

Abstract

Mucuna pruriens is widely known as “velvet bean,” which originally belongs to eastern part of India and China where it is cultivated as vegetable crop. It has been shown that its seeds are potentially of substantial medicinal importance. Kapikacchu belongs to Fabaceae family and it is widely used for aphrodisiac purpose as well as for Parkinson disease. It has lots of pharmacological properties such as hypoglycemic activity, antioxidant activity, aphrodisiac activity, antimicrobial properties and antiparkinsons activity. Parkinson’s disease is treated with the seeds of Mucuna pruriens which is the richest source of Levo-dopa. According to Ayurvedic literature Kapikacchu is used as a potent aphrodisiac, vermifuge and as a geriatric tonic. It is also used for the treatment of menstrual disorder, constipation, oedema, fever and tuberculosis.


Keywords: Anti-Parkinsonism, aphrodisiac, Kapikacchu, Levo-dopa, Mucuna pruriens

Cite this Article
Binod Bihari Dora, Shobhit Kumar. Kapikacchu (Mucuna pruriens): A Promising Indigenous Herbal Drug and Its Effect on Different Disease Conditions. Research & Reviews: A Journal of Toxicology. 2017; 7(3): 1–5p.


Downloads

Published

2018-01-24

Issue

Vol. 7 No. 3 (2017)

Section

Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.